Listed

Medical Properties Trust Inc

MPTNYSECIK 1287865Real estateFiscal year ends Dec 31

Latest reported revenue, Q1 FY2026$252.1mRevenue, Q1 FY2026, three months to 2026-03-31$252.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figureThree months to Mar 31, 2026, from the 10-Q filed May 8, 2026.

Latest quarter: Q1 FY2026

Three months to Mar 31, 2026, against the same quarter a year earlier.

  • Revenue$252.1mRevenue, Q1 FY2026, three months to 2026-03-31$252.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure+12.6% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
  • Net margin13.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Revenue: $252.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure+65.9 pts on a year earlier
  • Diluted EPS$0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figureSign changed from a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$252.1mNet margin 13.0%
Diluted EPS$0.05, Q1 FY2026
Medical Properties Trust Inc, key figures for the last eight quarters
Line itemUnitQ2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Shape over the periods
Revenue$m267Revenue, Q2 FY2024, three months to 2024-06-30$266.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure226Revenue, Q3 FY2024, three months to 2024-09-30$225.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure232Revenue, Q4 FY2024, three months to 2024-12-31$231.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure224Revenue, Q1 FY2025, three months to 2025-03-31$223.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure240Revenue, Q2 FY2025, three months to 2025-06-30$240.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure238Revenue, Q3 FY2025, three months to 2025-09-30$237.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure270Revenue, Q4 FY2025, three months to 2025-12-31$270.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure252Revenue, Q1 FY2026, three months to 2026-03-31$252.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%(120.3%)Net margin, Q2 FY2024, three months to 2024-06-30. net income / revenueNet income: −$320.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Revenue: $266.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(354.8%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$801.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Revenue: $225.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure(178.1%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$412.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Revenue: $231.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure(52.8%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$118.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Revenue: $223.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure(40.9%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$98.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Revenue: $240.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(32.7%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$77.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Revenue: $237.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure6.4%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Revenue: $270.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure13.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Revenue: $252.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Diluted EPS$ per share(0.54)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(1.34)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figurenot reported (Diluted EPS not reported)(0.20)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure(0.16)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figurenot reported (Diluted EPS not reported)0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$972.0mNet margin −28.5%
Diluted EPS−$0.46, FY2025
Medical Properties Trust Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,545Revenue, FY2021, twelve months to 2021-12-31$1.54bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-29, accession 0000950170-24-023248.Report this figure1,543Revenue, FY2022, twelve months to 2022-12-31$1.54bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure872Revenue, FY2023, twelve months to 2023-12-31$871.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure996Revenue, FY2024, twelve months to 2024-12-31$995.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure972Revenue, FY2025, twelve months to 2025-12-31$972.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%42.5%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $656.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-29, accession 0000950170-24-023248.Revenue: $1.54bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-29, accession 0000950170-24-023248.Report this figure58.5%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $902.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-03, accession 0000950170-25-030989.Revenue: $1.54bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure(63.8%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$556.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587.Revenue: $871.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure(242.1%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$2.41bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587.Revenue: $995.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure(28.5%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$277.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587.Revenue: $972.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure
Diluted EPS$ per share1.11Diluted EPS, FY2021, twelve months to 2021-12-31$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-29, accession 0000950170-24-023248.Report this figure1.50Diluted EPS, FY2022, twelve months to 2022-12-31$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure(0.93)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure(4.02)Diluted EPS, FY2024, twelve months to 2024-12-31−$4.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure(0.46)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Medical Properties Trust Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$347.7m75,253,906Reduced−43,975
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$202.2m43,755,548Added+670,784
STATE STREET CORP2026-06-30$118.5m25,162,287Reduced−398,922
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$100.4m21,742,204Added+906,637
AQR CAPITAL MANAGEMENT LLC2026-06-30$81.1m17,637,883Added+6,580,784
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2026-06-30$53.2m11,513,717Reduced−467,016
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$46.0m9,953,326Reduced−28,596
WILSEY ASSET MANAGEMENT INC2026-06-30$35.2m7,611,131Added+262,379
NORTHERN TRUST CORP2026-06-30$34.2m7,410,114Added+2,189,942
Allianz Asset Management GmbH2026-06-30$33.9m7,338,412Added+851,040

Recent filings

All 1,108 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Medical Properties Trust Inc, recent filings
FiledFormWhat it isAccession number
2026-08-1017:23 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-342713
2026-08-1016:52 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-342583
2026-08-1009:25 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-341434
2026-06-0116:55 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-26-251659
2026-05-0816:20 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-214700
2026-04-3008:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-194165
2026-04-1316:36 ETDEF 14AProxy statementPeriod 2026-04-130001193125-26-152971
2026-02-2608:31 ET10-KAnnual reportPeriod 2025-12-310001193125-26-073587
2026-02-1908:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-058167
2026-01-2008:56 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-016037

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 26, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1287865
Tickers
MPT
Exchange
NYSE
SIC code
6798 Real Estate Investment Trusts
Sector
Real estate
Fiscal year ends
Dec 31
Incorporated in
not reported
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:19 ET. Listed shows no prices and gives no investment advice.